Rekombinanter Senataxin (SETX) (AA 900-950) Antikörper
-
- Target Alle Senataxin (SETX) Antikörper anzeigen
- Senataxin (SETX)
- Antikörpertyp
- Recombinant Antibody
-
Bindungsspezifität
- AA 900-950
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB), Immunoprecipitation (IP)
- Verwendungszweck
- Rabbit anti-Senataxin Recombinant Monoclonal Antibody [BLR050F]
- Immunogen
- between AA 900 and 950
- Klon
- BLR050F
- Isotyp
- IgG
- Top Product
- Discover our top product SETX Primärantikörper
-
-
- Applikationshinweise
-
IP: 6 μL/1 mg lysate
WB: 17:40:00
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- Senataxin (SETX)
- Andere Bezeichnung
- Senataxin (SETX Produkte)
- Synonyme
- ALS4 antikoerper, SETX antikoerper, wu:fj92h09 antikoerper, AOA2 antikoerper, SCAR1 antikoerper, bA479K20.2 antikoerper, Als4 antikoerper, Sen1 antikoerper, AW060766 antikoerper, mKIAA0625 antikoerper, A130090N03 antikoerper, A930037J23Rik antikoerper, RGD1565575 antikoerper, senataxin antikoerper, SETX antikoerper, setx antikoerper, Setx antikoerper
- Hintergrund
- Background: Mutations in Senataxin result in the neurodegenerative disorders Ataxia-Oculomotor Apraxia 2 (AOA2) and amyotrophic lateral sclerosis (ALS4). Senataxin bears an RNA/DNA helicase domain suggesting a role in DNA and RNA processing and has recently been found to be involved in the DNA damage response.
- Gen-ID
- 23064
- NCBI Accession
- NP_055861
- UniProt
- Q7Z333
-